Evolutionary remodeling of a remnant GET pathway factor into PEX38, an essential peroxin

C Chethan K. Krishna (Department of Systems Biochemistry, Institute of Biochemistry and Pathobiochemistry, Faculty of Medicine, Ruhr University Bochum) S Stefan Gaussmann (Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Munich) H Hirak Das (Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg) M Martin Jung S Silke Oeljeklaus (Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg) M Michael Sattler B Bettina Warscheid (Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg) V Vishal C. Kalel (Department of Systems Biochemistry, Institute of Biochemistry and Pathobiochemistry, Faculty of Medicine, Ruhr University Bochum) R Ralf Erdmann (Department of Systems Biochemistry, Institute of Biochemistry and Pathobiochemistry, Faculty of Medicine, Ruhr University Bochum)

Abstract

PEX19 is a cytosolic receptor that directs membrane proteins posttranslationally to peroxisomes, as well as to mitochondria, lipid droplets, and the endoplasmic reticulum. A comprehensive Trypanosoma PEX19 interactome analysis uncovered PEX38 as an essential Euglenozoa-specific peroxin. PEX38 contains distinct domains that bind the cochaperone Hip and the PEX3-binding motif of PEX19, suggesting a role in stabilizing membrane proteins and preventing premature membrane docking. PEX38 illustrates functional repurposing in organelle biogenesis. It originated from a remnant of the GET/TRC pathway, typically responsible for the targeting of tail-anchored (TA) proteins to the endoplasmic reticulum. While most components of this machinery are absent in Euglenozoa, PEX38 has been retained and adapted to mediate peroxisomal membrane protein targeting. This evolutionary adaptation is unique to Euglenozoa. Because the PEX19–PEX38 interaction is essential for parasite viability and PEX38 has no human homologs, this complex is a promising therapeutic target against trypanosomatid parasites.

Article Details

Volume / Issue Vol. 123, Issue 9
Published March 03, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

C

Chethan K. Krishna

Department of Systems Biochemistry, Institute of Biochemistry and Pathobiochemistry, Faculty of Medicine, Ruhr University Bochum

S

Stefan Gaussmann

Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Munich

H

Hirak Das

Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg

M

Martin Jung

S

Silke Oeljeklaus

Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg

M

Michael Sattler

B

Bettina Warscheid

Biochemistry II, Theodor Boveri-Institute, Biocenter Faculty of Chemistry and Pharmacy, University of Würzburg

V

Vishal C. Kalel

Department of Systems Biochemistry, Institute of Biochemistry and Pathobiochemistry, Faculty of Medicine, Ruhr University Bochum

R

Ralf Erdmann

Department of Systems Biochemistry, Institute of Biochemistry and Pathobiochemistry, Faculty of Medicine, Ruhr University Bochum